Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

Similar articles for PubMed (Select 24835032)

1.

Prognostic impact of M2 macrophages at neural invasion in patients with invasive ductal carcinoma of the pancreas.

Sugimoto M, Mitsunaga S, Yoshikawa K, Kato Y, Gotohda N, Takahashi S, Konishi M, Ikeda M, Kojima M, Ochiai A, Kaneko H.

Eur J Cancer. 2014 Jul;50(11):1900-8. doi: 10.1016/j.ejca.2014.04.010. Epub 2014 May 15.

PMID:
24835032
2.

Impact of tumor-associated macrophages on invasive ductal carcinoma of the pancreas head.

Yoshikawa K, Mitsunaga S, Kinoshita T, Konishi M, Takahashi S, Gotohda N, Kato Y, Aizawa M, Ochiai A.

Cancer Sci. 2012 Nov;103(11):2012-20. doi: 10.1111/j.1349-7006.2012.02411.x. Epub 2012 Oct 4.

PMID:
22931216
3.

Nerve plexus invasion in pancreatic cancer: spread patterns on histopathologic and embryological analyses.

Makino I, Kitagawa H, Ohta T, Nakagawara H, Tajima H, Ohnishi I, Takamura H, Tani T, Kayahara M.

Pancreas. 2008 Nov;37(4):358-65.

PMID:
18972625
4.
5.

Prognostic impact of CD204-positive macrophages in lung squamous cell carcinoma: possible contribution of Cd204-positive macrophages to the tumor-promoting microenvironment.

Hirayama S, Ishii G, Nagai K, Ono S, Kojima M, Yamauchi C, Aokage K, Hishida T, Yoshida J, Suzuki K, Ochiai A.

J Thorac Oncol. 2012 Dec;7(12):1790-7. doi: 10.1097/JTO.0b013e3182745968.

PMID:
23154550
6.

Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinoma.

Chatterjee D, Katz MH, Rashid A, Wang H, Iuga AC, Varadhachary GR, Wolff RA, Lee JE, Pisters PW, Crane CH, Gomez HF, Abbruzzese JL, Fleming JB, Wang H.

Am J Surg Pathol. 2012 Mar;36(3):409-17. doi: 10.1097/PAS.0b013e31824104c5.

7.

Prognostic impact of para-aortic lymph node metastasis in pancreatic ductal adenocarcinoma.

Murakami Y, Uemura K, Sudo T, Hashimoto Y, Yuasa Y, Sueda T.

World J Surg. 2010 Aug;34(8):1900-7. doi: 10.1007/s00268-010-0577-2.

PMID:
20376442
8.

Detail histologic analysis of nerve plexus invasion in invasive ductal carcinoma of the pancreas and its prognostic impact.

Mitsunaga S, Hasebe T, Kinoshita T, Konishi M, Takahashi S, Gotohda N, Nakagohri T, Ochiai A.

Am J Surg Pathol. 2007 Nov;31(11):1636-44.

PMID:
18059219
9.

Intrapancreatic nerve invasion as a predictor for recurrence after pancreaticoduodenectomy in patients with invasive ductal carcinoma of the pancreas.

Shimada K, Nara S, Esaki M, Sakamoto Y, Kosuge T, Hiraoka N.

Pancreas. 2011 Apr;40(3):464-8. doi: 10.1097/MPA.0b013e31820b5d37.

PMID:
21289526
10.

Tumor associated macrophage expressing CD204 is associated with tumor aggressiveness of esophageal squamous cell carcinoma.

Shigeoka M, Urakawa N, Nakamura T, Nishio M, Watajima T, Kuroda D, Komori T, Kakeji Y, Semba S, Yokozaki H.

Cancer Sci. 2013 Aug;104(8):1112-9. doi: 10.1111/cas.12188. Epub 2013 Jun 4.

PMID:
23648122
11.

High expression of vascular endothelial growth factor predicts early recurrence and poor prognosis after curative resection for ductal adenocarcinoma of the pancreas.

Niedergethmann M, Hildenbrand R, Wostbrock B, Hartel M, Sturm JW, Richter A, Post S.

Pancreas. 2002 Aug;25(2):122-9.

PMID:
12142733
12.

Evaluation of surgical resection for pancreatic carcinoma at a Japanese single cancer institute.

Nanashima A, Tobinaga S, Abo T, Hatano K, Takeshita H, Nonaka T, Hidaka S, Tanaka K, Kunizaki M, Sawai T, Yasutake T, Nagayasu T.

Hepatogastroenterology. 2012 May;59(115):911-5. doi: 10.5754/hge10038.

PMID:
22469741
13.

Low serum level of cholinesterase at recurrence of pancreatic cancer is a poor prognostic factor and relates to systemic disorder and nerve plexus invasion.

Mitsunaga S, Kinoshita T, Hasebe T, Nakagohri T, Konishi M, Takahashi S, Gotohda N, Ochiai A.

Pancreas. 2008 Apr;36(3):241-8. doi: 10.1097/MPA.0b013e31815b6b2b.

PMID:
18362836
14.
15.

Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma: a predictor for patient outcome.

Chatterjee D, Katz MH, Rashid A, Varadhachary GR, Wolff RA, Wang H, Lee JE, Pisters PW, Vauthey JN, Crane C, Gomez HF, Abbruzzese JL, Fleming JB, Wang H.

Cancer. 2012 Jun 15;118(12):3182-90. doi: 10.1002/cncr.26651. Epub 2011 Oct 25.

16.

Ribonucleotide reductase M2 does not predict survival in patients with resectable pancreatic adenocarcinoma.

Xie H, Lin J, Thomas DG, Jiang W, Liu X.

Int J Clin Exp Pathol. 2012;5(4):347-55. Epub 2012 Apr 16.

17.

Surgical strategy for carcinoma of the pancreas head area based on clinicopathologic analysis of nodal involvement and plexus invasion.

Kayahara M, Nagakawa T, Ueno K, Ohta T, Tsukioka Y, Miyazaki I.

Surgery. 1995 Jun;117(6):616-23.

PMID:
7778025
18.

MUC4 expression is a novel prognostic factor in patients with invasive ductal carcinoma of the pancreas.

Saitou M, Goto M, Horinouchi M, Tamada S, Nagata K, Hamada T, Osako M, Takao S, Batra SK, Aikou T, Imai K, Yonezawa S.

J Clin Pathol. 2005 Aug;58(8):845-52.

19.

Prognostic significance of CD204-positive macrophages in upper urinary tract cancer.

Ichimura T, Morikawa T, Kawai T, Nakagawa T, Matsushita H, Kakimi K, Kume H, Ishikawa S, Homma Y, Fukayama M.

Ann Surg Oncol. 2014 Jun;21(6):2105-12. doi: 10.1245/s10434-014-3503-2. Epub 2014 Feb 4.

PMID:
24492923
20.

A prospective comparison of the prognostic value of tumor- and patient-related factors in patients undergoing potentially curative surgery for pancreatic ductal adenocarcinoma.

Jamieson NB, Denley SM, Logue J, MacKenzie DJ, Foulis AK, Dickson EJ, Imrie CW, Carter R, McKay CJ, McMillan DC.

Ann Surg Oncol. 2011 Aug;18(8):2318-28. doi: 10.1245/s10434-011-1560-3. Epub 2011 Jan 26.

PMID:
21267785
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk